Cambridge, MA, March 19, 2018 — The University of Southern California Keck School of Medicine, one of the preeminent research-intensive medical schools in the United States, has joined the TriNetX global health research network to help increase its clinical trial participation.
“We are looking forward to leveraging the TriNetX network to not only query our own patient population, but also collaborate with other healthcare organizations in the hopes of participating in additional clinical studies,” said April Armstrong, MD MPH, Associate Dean of Clinical Research at Keck School of Medicine at USC. “We were particularly attracted to TriNetX because of its user-friendly interface which makes conducting queries simple.”
TriNetX offers the fastest growing collaborative network of 70 healthcare organizations representing hundreds of facilities across 11 countries. TriNetX has presented over 1,300 clinical trial opportunities to its HCO members.
Network members utilize TriNetX’s cloud-based, health research platform to analyze patient populations and perform “what-if” analyses in real-time. As members, healthcare organizations receive hardware and software that are configured within the organization’s IT infrastructure and often builds on existing data resources such as i2b2 and Observational Medical Outcomes Partnership (OMOP). Researchers then have access to the institution’s de-identified patient data through a user-friendly interface and a growing number of visualization and analysis capabilities.
Biopharmaceutical companies and CROs are presented with aggregate views, but each data point in the TriNetX network can be traced to healthcare organizations who have the ability to identify individual patients. This enables clinical researchers to develop virtual patient cohorts that can then be re-identified for potential recruitment into a clinical trial.
USC is one of only two university-based medical systems in the Los Angeles area. Its two acute care hospitals have a total population of nearly 500,000 patients. The USC Clinical Trials Office is focused on serving patients, researchers, and sponsors by expediting clinical trials for novel and promising therapies.
“Having a prestigious academic institution like USC join TriNetX enhances the value of the entire network,” said Rachael Thomas Higgins, vice president of account management at TriNetX. “We look forward to helping them expand their clinical trial opportunities.”
The University of Southern California is one of only two university-based medical systems in the Los Angeles area. Encompassing academic, research, and clinical excellence, the medical system attracts internationally renowned experts who teach and practice at the Keck School of Medicine of USC, the region’s first medical school. USC includes the renowned Norris Comprehensive Cancer Center, one of the first comprehensive cancer centers established by the National Institutes of Health (NIH) in the U.S., a medical faculty practice, the USC Care Medical Group, the Keck Medical Center of USC, which includes two acute care hospitals, 401 licensed bed Keck Hospital of USC, Verdugo Hills Hospital, a 158-licensed bed community hospital, and more than 40 outpatient facilities in Los Angeles, Orange, Kern, Tulare, and Ventura counties. For more information visit https://clinicaltrials.usc.edu/.
TriNetX is the global health research network enabling healthcare organizations, biopharmaceutical companies and contract research organizations (CROs) to collaborate, improve research, enhance trial design, accelerate recruitment and bring new therapies to market faster. Each member of our community shares in the consolidated value of our global, federated health research network that connects clinical researchers in real-time to the patient populations which they are attempting to study. For more information, visit TriNetX at https://www.trinetx.com or follow @TriNetX on Twitter.